Showing results (641-650 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|August 7, 2012
Methods for retrospective detection of drug safety signals and adverse events in electronic general practice recordsAndrew Tomlin, David Reith, Susan Dovey, et al.
Drug Safety|July 27, 2012
Drug Fever: a descriptive cohort study from the French national pharmacovigilance databaseDominique Vodovar, Christine LeBeller, Bruno Mégarbane, et al.
Drug Safety|January 1, 1991
The adverse effects of angiographic radiocontrast mediaM Westhoff-Bleck, J S Bleck, S Jost
Drug Safety|July 14, 2012
Safety assessment of an anti-obesity drug (sibutramine): a retrospective cohort studyJerzy E Tyczynski, Denise M Oleske, David Klingman, et al.
Drug Safety|June 28, 2020
Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)Taylor M Patek, Chengwen Teng, Kaitlin E Kennedy, et al.
Drug Safety|July 1, 2020
Safety Profile of Ceftazidime-Avibactam: Pooled Data from the Adult Phase II and Phase III Clinical Trial ProgrammeKaren Cheng, Paul Newell, Joseph W Chow, et al.
Drug Safety|April 17, 2021
Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping ReviewSubhrojyoti Bhowmick, Amit Dang, B N Vallish, et al.
Drug Safety|August 29, 2012
Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence studyBetsabé Sánchez-Sánchez, Marina Altagracia-Martínez, Jaime Kravzov-Jinich, et al.
Drug Safety|October 16, 2012
Risk Communication and the Pharmaceutical Industry: what is the reality?Brian Edwards, Sweta Chakraborty
Drug Safety|October 18, 2012
Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™Lise Aagaard, Johanna Strandell, Lars Melskens, et al.
Pageof 308